Table-III.
Treatment and follow up of the studied patients.
| Patients | Treatment duration (months) ¤ | Follow up |
|---|---|---|
| 1 | 28 | Early complete response, absent relapse during treatment unavailability |
| 2 | 43 | Early complete response, absent relapse during treatment unavailability |
| 3 | 44 | Recurrent hypoglycemia, elevated triglycerides and uric acid |
| 4 | 60 | Recurrent hypoglycemia, no response to treatment (organomegaly) |
| 5 | 21 | No response to treatment (organomegaly) and low Platelets count |
| 6 | 24 | No response to treatment (organomegaly) |
| 7 | 24 | Signs not related to Gaucher disease |
| 8 | 37 | Symptoms of chronic liver disease, No response to treatment (organomegaly) |
| 9 | 26 | No response to treatment (organomegaly) |
| 10 | 24 | No response to treatment (organomegaly) |
| 11 | 2 | No response to treatment (organomegaly) |
| 12 | - | Elevated Lyso GL1 and positive family history of Gaucher disease |
| 13 | - | Elevated Lyso GL1 and positive family history of Gaucher disease |
¤
Treatment was ERT (Imiglucerase) 60 IU/kg every 2 weeks